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Abstract
The calpains are physiologically important Ca
2+-activated regulatory proteases, which are divided into typical or atypical
sub-families based on constituent domains. Both sub-families are present in mammals, but our understanding of calpain
function is based primarily on typical sub-family members. Here, we take advantage of the model organism Caenorhabditis
elegans, which expresses only atypical calpains, to extend our knowledge of the phylogenetic evolution and function of
calpains. We provide evidence that a typical human calpain protein with a penta EF hand, detected using custom profile
hidden Markov models, is conserved in ancient metazoans and a divergent clade. These analyses also provide evidence for
the lineage-specific loss of typical calpain genes in C. elegans and Ciona, and they reveal that many calpain-like genes lack
an intact catalytic triad. Given the association between the dysregulation of typical calpains and human degenerative
pathologies, we explored the phenotypes, expression profiles, and consequences of inappropriate reduction or activation of
C. elegans atypical calpains. These studies show that the atypical calpain gene, clp-1, contributes to muscle degeneration
and reveal that clp-1 activity is sensitive to genetic manipulation of [Ca
2+]i. We show that CLP-1 localizes to sarcomeric sub-
structures, but is excluded from dense bodies (Z-disks). We find that the muscle degeneration observed in a C. elegans
model of dystrophin-based muscular dystrophy can be suppressed by clp-1 inactivation and that nemadipine-A inhibition of
the EGL-19 calcium channel reveals that Ca
2+ dysfunction underlies the C. elegans MyoD model of myopathy. Taken
together, our analyses highlight the roles of calcium dysregulation and CLP-1 in muscle myopathies and suggest that the
atypical calpains could retain conserved roles in myofilament turnover.
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Introduction
Calpains are Ca
2+-regulated neutral thiol proteases that
perform a limited digestion of target substrates, and are thus
considered to be regulatory, as opposed to strictly degradative [1].
Members of the calpain family are variously composed of discrete
modular domains, numbered DI–DVI (Figure S1) [2,3]; DI–DIV
are domains associated with the large calpain catalytic subunit and
DV–DVI are domains found in a common small regulatory
subunit, named CAPNS1 (not shown) [4,5]. All calpain large
subunits share a signature domain DII, which contains the core
catalytic triad of cysteine, histidine and asparagine [6,7]. DII is
further divided into subdomains, IIa and IIb, which change
conformation to align the catalytic cleft upon binding of Ca
2+ [8].
DIII has a C2-like domain, which is present in almost all calpains,
whereas DI is usually composed of a short non-conserved sequence
that can undergo autolysis [6,7]. As discussed below, calpains
differ in their domain architecture; however, a key feature that
distinguishes the typical calpains from the atypical calpains is the
presence of DIV. The most extensively studied calpains are the
typical CAPN1 and CAPN2, which have a classic DIV composed
of five EF hand motifs, also referred to as a penta EF hand (PEF)
[4,5]. A PEF domain is also present in DVI of CAPNS1, which
heterodimerizes with CAPN1 and CAPN2 through DIV [4,5],
although not all typical calpains require CAPNS1 for activity [9–
11]. Mammalian genomes also encode the endogenous inhibitor
calpastatin, which is specific for typical calpains [12,13].
By contrast to typical calpains, there is no evidence indicating
that atypical calpains lacking DIV and EF hand motifs form
heterodimers. This absence of EF hands was also responsible for
the initial belief that atypical calpains were insensitive to Ca
2+
regulation [1]. Both typical and atypical calpains can also carry a
variety of alternative domains, including an additional C2-like
domain, zinc fingers, glycine rich regions and microtubule
interacting and transport (MIT) domains (Figure S1).
Genes encoding predicted calpain proteins have been identified
in many organisms ranging from single-celled yeasts to higher
vertebrates through the sequencing of whole genomes. Mamma-
lian genomes encode nine typical and five atypical calpains
[1,14,15]. The Drosophila genome encodes only three typical and
one atypical calpain (CALPD), also known as small optic lobes
(SOL) [16]. By contrast, the genome of the nematode C. elegans
encodes multiple atypical calpains, but no typical calpains. Given
the paucity of typical calpains in non-mammals, phylogenetic
arguments have been presented to suggest that the EF hand motifs
of typical calpains were late evolutionary additions [14]. Homologs
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calpain subunits, are also absent in C. elegans and Drosophila [16,17].
Mammalian calpains participate in many cellular processes,
including, but not limited to, cytoskeletal remodelling [18], cell
mobility [19], myofibril maintenance [20], signal transduction
[21], cell cycle progression [22], regulation of gene expression
[15], apoptosis [23] and long term potentiation [24]. Genetic
association studies have implicated calpains in disease pathologies
including limb-girdle muscular dystrophy type 2A (LGMD2A,
CAPN3) [25], susceptibility to type II diabetes (CAPN10) [26] and
gastric cancer (CAPN8/9) [27,28].
Despite their involvement in cell maintenance and disease, it
has been difficult to predict the targets of calpain proteolysis with
any precision, because substrate specificity is only weakly
determined by primary sequence [29,30]. In addition, a large
number of in vitro substrates have been identified, but many await
in vivo validation. Chemical calpain inhibitors have also been
developed, including active site peptidomimetics and domain IV
and VI non-peptidyl inhibitors [31]. Unfortunately, active site
inhibitors are generally not specific for calpains, as other cysteine
proteases, such as members of the cysteine cathepsin family, are
also subject to inhibition [32]; in addition, DIV and DVI
inhibitors would fail to inhibit atypical calpains.
By contrast to the many studies focused on the activity of the
typical calpains, it is clear that the specific involvement of atypical
calpains in development and disease pathologies remains under-
explored. We are using C. elegans as a model for exploring the
function of atypical calpains. Previous work in C. elegans has
highlighted the importance of the tra-3/clp-5 calpain gene in sex
determination [33,34]; other studies have shown that the C. elegans
clp-1 and tra-3/clp-5 genes are involved in neurodegeneration and
necrosis of a subset of vulval cells and in the intestine [35–37]. In
this paper, we have examined the evolution of atypical and typical
calpains in metazoa and analyzed the effects of reducing or
enhancing the activities of atypical calpains on C. elegans
development. To gain information about the potential site of
action of a subset of atypical calpain genes, we have examined
their in vivo expression patterns. Given the association between
calpain activity and degenerative pathologies, we have investigated
factors that influence the activity of clp-1 in a C. elegans model of
muscular dystrophy and reveal the importance of both sustained
calpain expression and intracellular Ca
2+ levels ([Ca
2+]i). Taken
together, we hypothesize that the muscle degenerative phenotype
caused by ectopic clp-1 stems from a conserved physiological role
for calpain in the turnover of sarcomeric muscle proteins.
Results
The C. elegans atypical calpain family
We searched the C. elegans genome sequence using the typical
human CAPN1 sequence and identified 14 atypical calpain-like
sequences. Seven of these genes had previously been named clp-1
to clp-7, so we named the remaining seven genes clp-8 to clp-10 and
clpr-1 to clpr-4 (for clp-related) for reasons explained below (Figure
S1). An earlier analysis predicted the existence of 17 C. elegans
calpain-like sequences [35]; however, three of these genes are not
valid family members. F44F1.1 is now considered to be a
pseudogene (Wormbase, release WS225), and both M04F3.4
and T21H3.3 lack a catalytic domain II, although they carry EF
hand motifs. The domain architecture of the C. elegans atypical
calpain proteins and the typical and atypical calpain proteins
found in humans and Drosophila is shown in Figure S1 for
comparison; a multisequence alignment is also provided to
highlight the conservation of catalytic domain II and the
divergence of DI and DIII among members of the calpain
superfamily (Figure S2).
The genome of C. briggsae, a nematode closely related to C.
elegans [38], only encodes nine predicted calpain sequences. To
explain this difference, we compared the sequences of calpain
proteins from C. elegans, C. briggsae, Drosophila and also human, and
generated a cladogram (Figure S3). By comparison to C. briggsae,i t
appears that a recent gene expansion specific to C. elegans created
two paralogous gene clusters. The first cluster consists of the C.
elegans CLP-9 (T11A5.6) and CLP-10 (W05G11.4) proteins, which
are homologous to C. briggsae Cbr-G19393; the proteins in this
cluster are each predicted to have a SolH domain. The second
cluster includes clp-8 (F44F1.3) and four predicted clpr genes,
which are missing a critical cysteine residue of the catalytic triad;
together these genes are paralogous to Cbr-G04776 and Cbr-
G00485, which encode proteins with an intact catalytic triad. The
existence of clpr genes raises the possibility that these predicted
calpains are inactive, or that they have possibly gained novel non-
proteolytic activities (Figure S1).
The cladogram in Figure S3 highlights the phylogenetic
relationships between the Caenorhabditis, Drosophila and human
calpain proteins. Although typical calpains are absent in C. elegans,
the CLP-2, TRA-3/CLP-5 and the paralogous CLP-9 and CLP-
10 proteins share extensive homology (E-values,1e-94) with
human CAPN7, CAPN5/CAPN6 and CAPN15, respectively
(Figure S3). Little is known about the biological functions of these
human atypical calpains; hence, an analysis of their C. elegans
homologs would provide potential insights into their function.
Ancient metazoan origins of typical and atypical calpains
We examined the evolutionary history of the typical calpains in
more depth to seek evidence that their absence in C. elegans might
be due to a lineage specific loss. We restricted our analyses to genes
in metazoan phyla, as an earlier study had shown that calpain
sequences containing C-terminal EF hand motifs are absent in
plants and fungi [14]. We were further aided by the availability of
whole genome sequences, particularly those representative of more
Author Summary
Calpains are calcium activated non-lysosomal proteases
that cleave proteins with exquisite selectivity. Proteins can
be activated by calpain cleavage, because they are
released from inhibitory constraints, or they can be
targeted for further degradation to facilitate their normal
physiological turnover or to promote cellular remodelling.
Inappropriate calpain activity can lead to degenerative
pathologies and cancers. Our understanding of calpain
function is based primarily on typical calpains, which carry
EF hand motifs that bind Ca
2+ or mediate dimerization;
however, typical and atypical calpains, which lack EF hand
motifs, are both present in mammals. Hence, any
therapeutic intervention designed to suppress degenera-
tive conditions, particularly those caused by elevated Ca
2+
levels, should also consider the potential involvement of
atypical calpains. We have taken advantage of the model
organism C. elegans, which only encodes atypical calpain
proteins, to gain an understanding of the evolution and
activities of these proteins. We show that the CLP-1
atypical calpain is normally expressed in muscle and
localizes to sarcomeric sub-structures. We find that CLP-1
contributes to the muscle degeneration observed in a
model of Duchenne muscular dystrophy. Our studies also
highlight the importance of calcium dysregulation in
promoting CLP-1 activity and muscle degeneration.
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cnidarians Nematostella vectensis and Hydra magnipapillata [39–41],
and also the sponge Amphimedon queenslandica, which diverged from
early metazoans over 600 million years ago [42]. We found that
homologs of typical calpains with EF-hand domains were likely to
be present not only in early metazoa, but also in sponge (Figure 1).
We also noted that typical calpain genes were absent from the
genomes of other nematodes, including P. pacificus, B. malayi and C.
remanei. Surprisingly, typical calpain genes were also absent in the
tunicate C. intestinalis, a primitive branching clade of chordates
[43], further supporting the notion of lineage-specific loss of typical
calpains. Genes encoding atypical calpain proteins, including those
carrying SolH or PBH domains, were also found in all metazoan
phyla examined and in sponge (Figure 1).
A profile hidden Markov model detects penta EF hand
domains
When analysing the phylogeny of the typical calpains, we found
that it was difficult to count EF-hand motifs in order to identify
penta EF-hand (PEF) domains using existing models [44]; for
example, PROSITE and pfam counted only four EF-hand motifs
and thus failed to identify PEF domains in CAPN1, 2 and 3 and
sorcin. The number of EF hand motifs is likely to affect the ability
of these proteins to dimerize, so we developed 5 separate custom
profile hidden Markov models (profile HMMs) based on the
individual EF hand motifs present within a penta EF hand domain
to improve the ability to count EF hand motifs [45] (Text S1, see
Materials and Methods). These profiles were tested by showing
that together they detected the presence of penta EF hand
domains in human CAPN1, CAPN2, CAPNS1 and sorcin
proteins (true positives), and their absence in human CAPN10
or the C. elegans atypical calpains (true negatives). Application of
these profiles to other typical calpain proteins showed that the
calpain from Trichoplax is predicted to have a penta EF hand
whereas the sponge has only four predicted motifs (Figure 1).
An abundance of calpain sequences with an incomplete
catalytic triad
As indicated above, many C. elegans calpain-like proteins are
predicted to lack proteolytic activity because the catalytic triad has
not beenconserved. Such inactive calpains have also been identified
in protozoa [14]. In humans, the atypical CAPN6 promotes
microtubule stability despite lacking a key residue within the
catalytic triad [46]. To examine the prevalence of calpain-like
proteins, we selected proteins that were missing at least one catalytic
residue by using Fast Statistical Alignment (FSA) to align 1234
proteins from the Uniprot database, which carry the signature
calpain catalytic domain SAAS022684_004_001783 [47,48]. After
removing protein fragments and splice variants from this list, a total
of 344 calpain-like proteins remained (Table S1). As might be
predicted, this analysis successfully identified the C. elegans, CLP-3
and CLPR-1 to CLPR-4, Drosophila CALPC and mammalian
CAPN6 proteins, which have incomplete catalytic triads. Surpris-
ingly, putative inactive calpain proteins were conserved across the
plant, animal and fungus kingdoms (Figure S4A), and were also
detected in protists (Figure S4B). Thus, taken together, the
abundance and retention of catalytically inactive calpains combined
with the finding that CAPN6 is functionally active might argue that
these proteins might have hitherto undiscovered functional roles.
Characterisation of C. elegans calpain mutants
Human pathologies, such as LGMD2A, an inherited autoso-
mal-recessive pathology caused by mutations in the typical calpain
CAPN3 gene [25], are associated with calpain dysregulation. To
determine whether the atypical calpain proteases participate in
physiological and degenerative processes similar to those attribut-
ed to typical calpains, we characterized C. elegans homozygous
mutants carrying deletions within the calpain genes clp-1, -4, -6, -7,
-8, -9, -10 and clpr-1; most of the deletions are predicted to disrupt
the catalytic domain and to reduce relative mRNA steady-state
levels by at least 70% (Table S2). In addition, we examined a clp-2
mutant carrying a Tc1 transposon inserted within an exon, and
performed clp-3 (RNAi) [49]. Phenotypic analysis revealed that
brood sizes were not significantly different from wild type for any
of the calpain mutants or clp-3 (RNAi) treated animals, except for
clp-10 (ok2713) mutants in which the average brood size was
reduced by approximately 50% (14468; n=4) without a
corresponding increase in embryonic lethality. Embryonic lethality
was slightly elevated in mutants carrying deletions in calpain
genes, but gross developmental, mobility or morphological defects
were not observed. For reasons discussed below, we also stained
the clp-1, -4, -6 and -7 deletion mutants with phalloidin, but failed
to detect disruptions to the sarcomeric structure of adult body wall
muscle (Figure S5). These results indicate that most calpain genes,
except for clp-10 and the previously characterized tra-3/clp-5 sex
determining gene [50], play non-essential roles in otherwise wild
type animals, although we have not addressed whether these genes
could be functionally redundant (Table S2).
Transcriptional expression profiles of clp-1 to clp-7
The typical CAPN1 and CAPN2 calpains are ubiquitously
expressed in cells (for review, [1]); however, a temporal elevation
in mouse CAPN2 mRNA levels was detected during an essential
period of embryonic development [51,52]. Other typical calpains
are capable of displaying more restricted patterns of expression;
for example, transcripts corresponding to CAPN3, the gene
affected in LGMD2A muscular dystrophy, are detected only in
skeletal muscle [25]. To gain insights into the potential roles of the
C. elegans atypical calpain genes based on their expression patterns,
we examined transgenic C. elegans carrying nuclear-localized
mRFP transcriptional reporters driven from promoter regions
corresponding to clp-1 to -7. A nuclear localization signal was
included to facilitate tissue-specific localization. mRFP was
expressed from all of the reporters, except clp-3 and clp-6 (Figure
S6); only the clp-2 reporter showed limited expression confined to
the intestine (Figure S6). These expression patterns remained
unchanged over the course of larval development through to
adulthood (Figure S7).
To aid in the identification of tissues displaying calpain gene
expression, clp(p)::nls::mRFP transcriptional reporters were co-
expressed in animals carrying one of five different tissue-specific
GFP reporters (for details, see Materials and Methods). We found
that the clp-1, -4 and -7 reporters were active in neurons and co-
localized with both the pan-neural unc-119::gfp and the GABAergic
unc-47::gfp reporters, whereas the tra-3/clp-5 reporter was only
detected in non-GABAergic neurons (Figure 2 and Figure S8). In
addition, the clp-1 and clp-4 reporters were expressed in cells of the
ventral and dorsal nerve cords, whereas the tra-3/clp-5 and clp-7
reporters were only expressed in cells of the ventral nerve cord
(Figure 2 and Figure S8). Given the association between human
CAPN3 and LGMD2A [25], we next co-expressed the clp reporters
with the body wall muscle marker myo-3p::gfp::nls and found that
only the clp-1 and clp-4 promoters were active in muscle (Figure 3A,
3B).
mRFP expressed from the clp-4, tra-3/clp-5 and clp-7 gene
promoters also co-localized with a pes-6::gfp reporter, a marker for
the excretory cell, which serves as the renal system of the worm
Calpain Evolution and Muscle Degeneration
PLoS Genetics | www.plosgenetics.org 3 March 2012 | Volume 8 | Issue 3 | e1002602Figure 1. Phylogenetic analyses of typical calpains in metazoa support a model of lineage-specific loss. Typical calpain EF hand motifs
in DIV are highlighted; C-terminal EF hand motifs are absent in Nematoda and Ciona intestinalis. Other domains associated with calpain proteins
include: PBH, PalB homology domain with some domain III homology; T/C2, C2 domain originally identified in TRA-3 [33]; Zn
2+, zinc finger motif-
containing; SolH, small optic lobes (SOL) homology domain; MIT 1, microtubule interacting and transport domain; and UCTH1, ubiquitin carboxyl-
terminal hydrolase domain. The number of genes encoding proteins with the indicated modular arrangement of domains is indicated, left; the
number of EF hands in DIV predicted by custom profile hidden Markov models are shown, right. Clades abbreviations: M, Metazoa; Pl, Placozoa; Eu,
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tional reporter co-localized with the seam cell reporter scm::gfp
(Figure 3F). Calpain transcriptional reporters were also detected in
other tissues, including the intestine (clp-1, -2, -7 and tra-3/clp-5),
vulva (clp-1, tra-3/clp-5 and clp-7) and hypodermis (tra-3/clp-6 and
clp-7) (Figure S9). The expression profiles of the clp-1 to clp-7
mRFP transcriptional reporters are summarized in Table 1.
Ectopic expression of CLP-1 in muscle causes paralysis
Increased calpain activity is associated with degenerative
pathologies, such as cataract, neuronal degeneration and muscular
dystrophy [25,53–55]. Since a reduction in calpain activity failed
to produce readily observable degenerative phenotypes in C.
elegans, we next investigated the consequences of increasing calpain
activity. This was first achieved by ectopically expressing full-
length clp-1, -2, -4, -7 and tra-3/clp-5 cDNAs under the control of
the inducible hsp-16.41 promoter, which is activated by heat shock
in almost all tissues, except the germ line [56]. At least three
independent transgenic strains were generated and tested for each
construct; however, despite subjecting transgenic animals to daily
doses of heat-shock driven calpain expression, we failed to detect
abnormal phenotypes in any of the transgenic lines (n.1000 for
each strain).
We considered the possibility that the transient nature of heat
shock induced gene expression was insufficient for the purpose of
Eumetezoa; C, Cnidaria; B, Bilateria; P, Protostomia; D+Ch, Deuterostomia and Chordata; L, Lophotrochozoa; E, Ecdysozoa; N, Nematoda and A,
Arthropoda. The tree is not drawn to scale. Protein accession numbers are available in Materials and Methods.
doi:10.1371/journal.pgen.1002602.g001
Figure 2. Co-localization of the pan-neuronal unc-119::gfp
reporter with calpain nls-mrfp transcriptional reporters. (A) clp-
1p::nls-mrfp (crEx65) is expressed in the ventral and dorsal (B) nerve
cord. (C) clp-4p::nls-mrfp (crEx74) is expressed in the ventral and dorsal
nerve cord. (D) tra-3p::nls-mrfp (crEx78) and (E) clp-7p::nls-mrfp (crEx79)
are each expressed in the ventral nerve cord. Sites of co-localisation
between clp-1p::nls-mrfp, clp-4p::nls-mrfp, tra-3p::nls-mrfp or clp-7p::nls-
mrfp with unc-119::gfp expressed in ventral neuronal cell bodies are
highlighted with white arrowheads; similarly, sites of co-localisation
between clp-1p::nls-mrfp or clp-4p::nls-mrfp with unc-119::gfp expressed
in dorsal neuronal cell bodies are highlighted with white arrows. Each
micrograph is typical of the pattern observed with at least two other
independent transgenic strains generated with the same reporter
construct. unc-119::gfp, left (green); calpain promoter nls-mrfp, middle
(red); and co-localization, right (yellow). Scale bar is 10 mM.
doi:10.1371/journal.pgen.1002602.g002
Figure 3. Calpain nls::mrfp expression in non-neuronal tissues.
Co-localization of the myo-3p::gfp::nls body wall muscle reporter with
(A) clp-1p::nls::mrfp (crEx65) and (B) clp-4p::mrfp (crEx74). Co-localization
of the pes-6::gfp excretory cell reporter with (C) clp-4p::nls::mrfp (crEx74),
(D) tra-3p::nls::mrfp (crEx78) and (E) clp-7p::nls::mrfp (crEx79). (F) Co-
localization of the scm::gfp seam cell reporter with clp-7p::nls::mrfp
(crEx79). Tissue-specific GFP reporter, left (green), calpain promoter
driven nls::mrfp expression, middle (red) and co-localization, right
(yellow) highlighted with arrows. Each micrograph is typical of the
pattern observed with at least two other independent transgenic strains
generated with the same reporter construct. Scale bar, 10 mM.
doi:10.1371/journal.pgen.1002602.g003
Calpain Evolution and Muscle Degeneration
PLoS Genetics | www.plosgenetics.org 5 March 2012 | Volume 8 | Issue 3 | e1002602eliciting ectopic phenotypes. To test this hypothesis, the constitu-
tively active unc-54 promoter was used to drive ectopic expression
of calpain cDNAs in body wall muscle [57]. Strikingly, we
observed that the unc-54p::clp-1::myc transgene crEx325 caused
1.5%60.4% of adult animals to develop paralysis (n.1000);
similar results were obtained for two other independent transgenic
lines (data not shown). Affected animals displayed an uncoordi-
nated (Unc) phenotype at the L4/early adult stage, which
progressed to paralysis and finally to premature death as animals
matured to day 2 adults (Figure S10). This effect was not observed
when the other muscle-associated gene, clp-4, was constitutively
expressed from the unc-54 promoter, nor when clp-2, -7 or tra-3/
clp-5 cDNAs were similarly expressed.
CLP-1–induced paralysis is dependent on expression
levels and an intact catalytic triad
To understand why the hsp-16.41p::clp-1 transgene failed to
cause paralysis, we compared the levels of CLP-1::MYC expressed
from either the muscle-constitutive crEx325 [unc-54p::clp-1::myc]o r
the heat shock activated crEx329 [hsp-16.41p::clp-1::myc] transgene
by western blot analysis (Figure S11A). We also observed that the
level of CLP-1::MYC expressed from crEx329 peaked between 4 to
12 hours post-heat shock before declining (Figure S11B). By
comparison, the level of CLP-1::MYC expressed from the crEx325
transgene was four-fold higher than that observed during the peak
of crEx329 heat shock driven expression. These results indicate
that sustained levels of elevated CLP-1 protein promote the
development of paralysis.
To establish that an intact catalytic triad was required for CLP-
1 to cause paralysis, four independent lines were established that
were predicted to express a catalytically inactive CLP-1(C371A)
from an unc-54p::clp-1(C371A) transgene [58], but none showed
mobility defects or paralysis (n.1200). Additional lines expressing
mRFP tagged CLP-1 proteins were generated to facilitate western
blot analysis. In these lines, paralysis was not detected in crEx336
[unc-54p::clp-1(C371A)::mrfp] animals (n.1200), whereas paralysis
developed in 1.9%60.6% (n.300) of crEx335 [unc-54p::clp-1::mrfp]
animals. We also observed that the level of CLP-1::mRFP
expressed from crEx336, as measured by western blot analysis,
was not reduced when compared to crEx335, and so could not
account for the difference in their activities (Figure S11C).
Attempts were also made to demonstrate CLP-1 proteolytic
activity using casein zymography and the calpain-GLO protea-
se
TM assay (Promega), which are used to measure typical calpain
activity [59]. Unfortunately, neither casein nor suc-LLVY-
aminoluciferin was found to be a suitable substrate for CLP-1,
although a similarly prepared recombinant rat CAPN2 was active
in both assays.
Ectopic expression of clp-1 in neurons fails to elicit
neurodegenerative or neuromuscular defects
We next examined clp-1 activity in neurons. Previous studies
have shown that RNAi inactivation of clp-1 partially suppressed
the degeneration of touch receptor neurons in animals carrying
gain-of-function mutations in the mec-4 or deg-1 Na
+ channel
subunits [35], although degeneration was not observed when clp-1
was overexpressed in touch receptor neurons [35]. We also tested
and failed to observe neurodegenerative phenotypes when either
the unc-119p::clp-1 or unc-47::clp-1 reporter was expressed in other
neurons.
Ectopic expression of clp-1 causes muscle cell
abnormalities
In N2 wild type animals, body wall muscle cells form striated
diamond shaped bundles that are arranged into four quadrants
running down the length of the animal [60]. We hypothesized that
constitutively elevated expression of CLP-1 in body wall muscle
cells was causing extensive myofibrillar damage, which in turn was
leading to paralysis. Before examining muscle morphology, we
chromosomally integrated the crEx325 [unc-54p::clp-1] array to
generate crIs4, in order to circumvent potential problems
associated with mosaic expression [61]. We found that the
integrated crIs4 array retained the same phenotypic characteristics
as crEx325; 1.6960.34 (n=352) of crIs4 animals displayed
paralysis. We next synchronized the growth of crIs4 worms and
separated crIs4 adults into three distinct classes: 1) phenotypically
wildtype with normal sinusoidal movement 2) Unc and 3)
paralyzed, and examined the integrity of body wall muscles by
staining actin thin filaments with phalloidin. We found that
phenotypically wildtype crIs4 animals exhibited only occasional
Table 1. Summary of C. elegans calpain transcriptional reporter expression patterns.
Cell type
Promoter Muscle
a Neuronal Intestinal Hypodermal Excretory Seam
clp-1
b ++
c,d ++ 22
clp-2 22 +
d 22 2
clp-3
f 22 2 2 2 2
clp-4 ++
c,d 2 ++ 2
tra-3/clp-5 2 +
c,g +
h ++ 2
clp-6
f 22 2 2 2 2
clp-7 2 +
c ++ + +
aBody wall muscle.
bExpression detected with both transcriptional and translational fusions.
cVentral nerve cord.
dDorsal nerve cord.
eExpression is restricted to the intestine.
fNo expression detected throughout animal.
gAbsent in GABAergic neurons highlighted with unc-47p::gfp (EG1285).
hEnhanced expression detected in pair of anterior-most intestinal nuclei.
doi:10.1371/journal.pgen.1002602.t001
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animals displayed disorganized bundles of actin fibers and were
also missing body wall muscle cells (Figure 4B, Table 2). These
abnormalities were even more extensive in paralyzed crIs4 animals
(Figure 4C, Table 2). Thus, the paralysis observed in crIs4 animals
can be attributed to the loss of sarcomere integrity.
CLP-1 localizes to muscle M-lines and adhesion plaques
Given that CLP-1 promotes the degeneration of body wall
muscle, we examined the intracellular localisation of CLP-
1::mRFP in qyIs43 animals co-expressing a beta-integrin subunit
[pat-3::gfp] (Figure 5) [62]; in muscle cells, PAT-3 is found at the
base of thick filament M-lines, dense bodies (Z-disks) and in
adhesion plaques that are formed between adjacent cells
(Figure 5A). We found that CLP-1::mRFP was excluded from
the nucleus (not shown) and dense bodies, but was present at
structures immediately adjacent to dense bodies (Figure 5B). More
specifically, CLP-1::mRFP co-localized with PAT-3::GFP at M-
lines extending over the H-zone and at adhesion plaques
(Figure 5C). We also generated a native clp-1::gfp translational
reporter, which confirmed that CLP-1::GFP displayed the same
pattern of sarcomeric localization, as CLP-1::mRFP driven from
the unc-54 promoter (Figure 5D and Figure S12); CLP-1::GFP was
also detected in other non-muscle tissues. Aggregates of CLP-
1::mRFP were also observed, which might contribute to muscle
degeneration and paralysis, although we cannot exclude the
possibility that aggregation is an artifact of overexpression
(Figure 5B). Thus, we speculate that sarcomeric proteins enriched
at the sites of CLP-1 localization are potential targets for
degradation.
Reduction of CLP-1 activity suppresses muscle
degeneration in a C. elegans model of muscular
dystrophy
In mammals, the absence of the large structural muscle protein
dystrophin underlies the muscle degenerative disorder Duchenne
muscular dystrophy (DMD) [63]. Similarly, a C. elegans DMD
model is based on the progressive muscle degeneration observed in
dys-1(cx18); hlh-1(cc561ts) animals [60]. In C. elegans, a null mutation
in the only dystrophin-like protein gene, dys-1(cx18), caused only
occasional muscle degeneration [64]. However, inclusion of a
temperature sensitive allele of the MyoD transcription factor
homolog, hlh-1(cc561ts), sensitized dys-1(cx18); hlh-1(cc561ts) mu-
tants to become uncoordinated (Unc), but not paralyzed, and to
display increased muscle degeneration [60].
We investigated whether CLP-1 contributed to the muscle
degeneration associated with C. elegans DMD by constructing the
dys-1(cx18); hlh-1(cc561ts); clp-1(tm690) strain. The clp-1(tm690)
mutation deletes a 624 bp region of the clp-1 gene and introduces
a translational frame-shift that is predicted to produce a 493 amino
acid truncated protein, which lacks two of the three critical
catalytic residues required for proteolytic activity. clp-1 (tm690)
mutants are phenotypically wild-type and do not display any
obvious defects in their muscle structure (Table 2, Figure S5).
When the number of abnormal muscle cells present in dys-1(cx18);
hlh-1(cc561ts); clp-1(tm690) was compared to that found in dys-
1(cx18); hlh-1(cc561ts) animals after phalloidin staining, we found
that the absence of clp-1 reduced the number of abnormal muscle
cells by almost 50% (p,0.001). A body wall muscle cell was scored
as abnormal when: 1) the classic striated pattern of actin filaments
was disrupted 2) actin bundles were visible as puncta or 3) muscle
cells were missing due to cell death. Thus, clp-1 is normally active
in muscle and contributes to the muscle degeneration observed in
dys-1(cx18); hlh-1(cc561ts) animals (Table 2).
Genetic manipulation of [Ca
2+]i levels exacerbates clp-1–
induced paralysis
Although ectopic expression of CLP-1 led to a degradative
muscle pathology, we were surprised that the penetrance of the
effect was not higher. To ask what other factors might modulate
clp-1 activity in muscle, we first took a genetic approach to
investigate the effect of intracellular calcium [Ca
2+]i. Although
calpains are referred to as Ca
2+-activated proteases, little is known
about the effect of physiological calcium levels on the activity of
atypical calpains. In C. elegans, four allelic modifiers have been
identified that are understood to increase [Ca
2+]i: egl-19(ad695gf),
itr-1(sy290gf), slo-1(js379) and unc-24(e138) (for descriptions of
mutants, see Materials and Methods). We generated strains
carrying each of these mutations in combination with crIs4 and
scored adults for paralysis.
We found that the number of animals displaying paralysis was
significantly increased when crIs4 was combined with mutations in
egl-19(ad695), unc-24(e138) or slo-1(js379) (Figure 6A). Inclusion of
the egl-19(ad695gf) mutation produced the most dramatic increase
in paralysis (p,0.001), whereas the unc-24(e138) mutation caused a
mild, but significant increase (p=0.043) (Figure 6A). Although the
slo-1(js379) mutation also increased the level of crIs4 paralysis, this
effect could be attributed to either its role in Ca
2+ regulation or to
its participation in the Dystrophin Associated Protein Complex
(DAPC), discussed below [65]. The itr-1(sy290gf) mutation did not
significantly affect the number of paralyzed crIs4 animals;
however, ITR-1 expression has not been detected in muscle [66].
Table 2. Deletion of C. elegans clp-1 partially suppresses
dystrophin-based muscle degeneration.
Genotype
Abnormal body wall muscle
cells
a
crIs4 wildtype-like 0.260.1
crIs4 Unc 11.061.0
crIs4 paralysed 33.860.6
clp-1(tm690) 0.060
dys-1(cx18);hlh-1(cc561ts) 10.960.4
dys-1(cx18);hlh-1(cc561ts); clp-1(tm690) 5.960.6
b
aWorms were grown at 15uC, and scored as Day 2 adults. Following phalloidin
staining, the 20 most central muscle cells from each of the two most visible
body wall muscle quadrants were scored (40 cells per animal), as described in
Gieseler et al. (2000). Number represents the mean 6 standard deviation from 3
independent experiments involving at least 30 animals per experiment.
bReduction is significantly different based from dys-1(cx18); hlh-1(cc561ts) based
on Student’s t-test (P,0.001).
doi:10.1371/journal.pgen.1002602.t002
Figure 4. Ectopic crIs4 [unc-54p::clp-1] expression disrupts body
wall muscle. (A) Typical pattern of muscle striations in phenotypically
wildtype crIs4 adults. (B) Unc crIs4 animal showing loss of actin striations
(arrowhead). (C) Paralyzed crIs4 animal with bundled muscle cells
(dashed ring) and missing muscle cells (arrowhead). Scale bar, 10 mm.
doi:10.1371/journal.pgen.1002602.g004
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Complex (DAPC) do not enhance clp-1–induced paralysis
We next constructed a set of double mutants between crIs4 and
members of a second group of allelic modifiers that form the
Dystrophin Associated Protein Complex (DAPC): dys-1(cx18), snf-
6(ok720), dyb-1(cx36) and stn-1(ok292), which encode a dystrophin-
like protein, acetylcholine transporter, dystrobrevin and syntro-
phin, respectively [64,67–69]. Constituents of the DAPC provide
structural support to muscle by linking the cytoskeleton to the
sarcolemma and extracellular matrix [70]. We hypothesized that
mutations capable of destabilizing the integrity of the DAPC could
sensitize muscle cells to CLP-1 induced damage. The four mutants
listed above and slo-1(js379) share a similar phenotype marked by
hyperactivity and exaggerated head bending [64,65,67–69]. An
hlh-1(cc561ts) temperature sensitive allele of a MyoD homolog was
also examined because this mutation sensitizes dystrophin dys-
1(cx18) mutants to muscle damage [60].
We found that disrupting the structural proteins of the DAPC
complex did not significantly sensitize animals to the effects of
ectopic clp-1 provided by crIs4 (Figure 6B). By contrast, inclusion of
the hlh-1(cc561ts) allele substantially increased the proportion of
paralyzed crIs4 animals. We next tested whether the effects of crIs4
could be further enhanced in a dys-1(cx18); egl-19(ad695gf) genetic
background by increasing [Ca
2+]i. Adult dys-1(cx18); egl-19(ad695gf)
double mutants in the absence of crIs4 are Unc, but not paralyzed,
and exhibit moderate muscle degeneration [71]. We found that
the percentage of dys-1(cx18); egl-19(ad695gf); crIs4 adults develop-
ing paralysis was vastly elevated (56.366.4%) when compared to
animals expressing crIs4 in combination with a mutation in either
dys-1(cx18)o regl-19(ad695gf) alone (Figure 6B). Moreover, the
brood size of dys-1(cx18); egl-19(ad695gf); crIs4 animals was
dramatically reduced and embryonic lethality elevated (Table S3).
The heightened sensitivity of dys-1(cx18); egl-19(ad695gf) mutants
to crIs4 induced paralysis led us to investigate whether dys-1(cx18);
Figure 6. Genetic enhancers of crIs4 [unc-54p::clp-1] induced paralysis. (A) Genetic mutations in calcium channel genes that are predicted to
increase [Ca
2+]i enhance crIs4 [unc-54p::clp-1] induced paralysis. (B) DAPC mutants do not enhance crIs4 [unc-54p::clp-1] induced paralysis unless
combined with a mutation that also increases [Ca
2+]i. Percentages represent the mean 6 SEM from at least 4 independent experiments, which
involved counting day 2 adults from synchronized worm populations (see Materials and Methods). For each experiment an n.120 was used, except
for the strains crIs4 and dys-1(cx18); egl-19(ad695); crIs4 where an n.60 was used. In the absence of crIs4, none of the mutant genotypes led to
paralysis (n.100, for each strain). unc-24 mutants are Unc, but not paralyzed. Significance of difference by comparison to crIs4 is based on Student’s
T-test (*, P,0.001) and (**, P=0.043).
doi:10.1371/journal.pgen.1002602.g006
Figure 5. Ectopic unc-54p::clp-1::mrfp localizes to M-lines and adhesions plaques in body wall muscle. (A) pat-3p::gfp integrin reporter
(green) localizes to the M-lines, dense bodies and adhesion plaques. (B) unc-54::clp-1::mrfp (red) is expressed in sarcomeres and forms aggregates. (C)
Co-localization of unc-54::clp-1::mrfp (red) (B) with the pat-3p::gfp integrin reporter (green) (A) at the M-line extending over the H-zone and adhesion
plaques. unc-54::clp-1::mrfp does not co-localize at dense bodies. (D) clp-1::gfp shows a similar pattern of expression as (B), but is also expressed in
neuronal structures marked with an asterisk. M-line, small arrowhead; H-zone, bracket; dense body (Z-disk), arrow; aggregates, open arrowhead;
adhesion plaques, large arrowhead. Scale bar is 10 mm.
doi:10.1371/journal.pgen.1002602.g005
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ectopic clp-2, -4, -7 or tra-3/clp-5 expression in muscle under
control of the unc-54 promoter. We examined over 1000 animals
from at least three independent transgenic lines for each calpain,
however, we failed to detect any exacerbated defects in movement
aside from those already reported for dys-1(cx18); egl-19(ad695gf)
mutants [71]. Hence, of the calpains tested, only clp-1 was found to
induce paralysis when overexpressed in muscle under conditions of
elevated [Ca
2+]i.
Inhibition of the egl-19 channel reduces clp-1–induced
paralysis
The EGL-19 L-type voltage gated Ca
2+ channel is located along
the basal membrane of muscle. To demonstrate that egl-19(gf) was
exerting an effect on clp-1 activity specifically by altering [Ca
2+]I,
we asked if the small molecule antagonist, nemadipine-A, could
suppress CLP-1 mediated muscle degeneration; nemadipine-A has
been shown to be a specific and highly effective inhibitor of EGL-
19 [72]. We found that a dose of 5 mM nemadipine-A was
sufficient to abolish the enhanced level of paralysis observed in egl-
19(ad695); crIs4 mutants (Figure 7A). We next treated hlh-
1(cc561ts); crIs4 mutants with nemadipine-A and found that
paralysis was also reduced by over 50% compared to untreated
animals (Figure 7A). This result indicates that the hlh-1(cc561ts)
mutation is likely to sensitize muscle cells to the effects of crIs4
indirectly by causing an increase in [Ca
2+]I, which can be
suppressed by inhibiting the activity of the EGL-19 Ca
2+ channel.
RNAi inactivation of aspartyl proteases suppresses clp-1–
induced paralysis
The aspartyl proteases, asp-1, asp-3 and asp-4, have previously
been shown to be constituents of a neural degenerative pathway
involving the calpains clp-1 and tra-3/clp-5 [35]. To ask if the asp
genes also promote muscle degeneration, we performed RNAi
with the genes asp-1 to asp-6 on hlh-1(cc561ts); crIs4 animals. The
effectiveness of RNAi knockdown was measured by quantitative
PCR (qPCR) (Table S4). We found that asp-3(RNAi) reduced
paralysis levels by over 40% and that asp-2(RNAi) and asp-4(RNAi)
each reduced paralysis by ,15%, whereas asp-1(RNAi) had no
measurable effect in muscle. We further showed that clp-1(RNAi)
almost completely abolished crIs4 induced paralysis in hlh-
1(cc561ts); crIs4 animals, as might be expected (Figure 7B).
Discussion
Typical and atypical calpains are both detected in ancient
metazoan phyla
CAPN1 and CAPN2 are still referred to as the main or major
calpains despite the rich variety and abundance of genes encoding
atypical calpain proteins (Figure 1). However, phylogenetic
analyses performed here and by others indicate that the C-
terminal EF hand motifs in typical calpains are unlikely to
represent embellishments acquired late in metazoan evolution, as
might be inferred by the greater importance attached to typical
calpains [1,14]. We detected typical calpain homologs in basal
metazoan phyla, such as Nematostella, Trichoplax and Hydra
[39–41], as well as in sponge, a representative of an early divergent
metazoan clade [42], and found that the EF hand domain in early
metazoan typical calpain proteins was already composed of 5
motifs (PEF) (Figure 1). The absence of typical calpain genes in C.
elegans and the presence of both typical and atypical calpain genes
in Schistosomes and Drosophila further suggests that C. elegans is
likely to have undergone a lineage-specific loss of typical calpain
genes; it is noteworthy that Drosophila and C. elegans have both
been assigned to the clade Ecdysozoa [73]. A similar line of
reasoning could also be used to explain the absence of typical
calpain genes in the genome of the ascidian Ciona [43].
Studies directed toward understanding the function and
regulation of atypical calpains have lagged, or have possibly been
confounded by the presence of typical calpains. C. elegans presents
an ideal model in which to examine the function of atypical
calpains, because their genome encodes a range of variants that
are representative of those found across phyla, including ancient
metazoan lineages, and because of the availability of mutant alleles
(Figure S1). Our analyses of these mutants have shown that clp-
10(ok2713) mutants have a reduced brood size, but that the
remaining mutants, with the exception of tra-3/clp-5, do not
Figure 7. Small molecule and genetic inhibition of crIs4 [unc-54p::clp-1] induced paralysis. (A) Treatment with 5 mM nemadipine-A reduced
crIs4 [unc-54p::clp-1] induced paralysis in egl-19(ad695); crIs4 and hlh-1(cc561ts); crIs4 animals. % paralyzed animals for each strain are indicated with
(+) or without (2) nemadipine-A treatment. Significance of difference based on Student’s T-test compared to egl-19(ad695); crIs4 (*, P,0.001) or hlh-
1(cc561ts); crIs4 (**, P=0.001) without nemadipine-A treatment. (B) Treatment of hlh-1(cc561ts); crIs4 animals with empty RNAi feeding vector (L4440),
clp-1,o rasp-1 to asp-6 (RNAi). Significance of difference compared to hlh-1(cc561ts); crIs4 fed on empty vector (RNAi) is based on Student’s T-test (*,
P,0.001; **, P,0.05). Numbers shown represent the mean 6 SEM from at least 5 independent experiments, which involved counting day 2 adults
from synchronized worm populations (see Methods). n.60 per experiment.
doi:10.1371/journal.pgen.1002602.g007
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[50]. Seven of the nine characterized mutants are represented by
null or strong loss-of-function alleles that have eliminated or
disrupted the catalytic triad; qPCR also shows that levels of
affected transcripts were reduced in mutants by at least 70%
(Table S2). Despite our inability to detect single mutant
phenotypes, our results demonstrated that deletion of clp-1
suppressed muscle degeneration in dys-1(cx18); hlh-1(cc561ts)
mutants (Table 2). In neurons, it was similarly shown that RNAi
knockdown of either clp-1 or tra-3/clp-5 suppressed touch cell
degeneration in mutants carrying a dominant-gain-of-function
mec-4 allele [35]. These results indicate that the ability to detect
phenotypes in atypical calpains might be dependent on the genetic
background or physiological state of the animal. It also remains
possible that the expansion in the family of C. elegans atypical
calpain genes has made it difficult to detect single mutant
phenotypes because of functional redundancy.
Regulation and specificity of atypical calpain activity
To gain insights into the physiological roles of atypical calpain
proteins, we examined the consequences of calpain overexpres-
sion, but were unable to detect any obvious phenotypic changes
resulting from heat-shock driven overexpression. CLP-1 protein
expressed under these conditions peaked 4–8 hours post heat-
shock before declining; by contrast, the level of CLP-1 protein
resulting from unc-54 promoter activity was shown to be
comparable to that detected during the peak period of expression
after heat shock (Figure S11). The near-absence of phenotypes
resulting from calpain overexpression could also indicate that
enhanced atypical calpain activity is not necessarily detrimental in
a healthy cell. One could speculate that if a given atypical calpain
were constitutively active, then overexpression might have limited
effect. For example, although heat shock driven expression of a
wildtype tra-3/clp-5 transgene was clearly sufficient to prevent the
sexual transformation of a tra-3/clp-5 null mutant, rescued animals
did not display any degenerative phenotypes [34].
The substrate specificity of typical calpains is determined not
only by primary sequence, but also by higher order structural
features [30]. Very little is known about the substrate requirements
for atypical calpains, but in our hands, CLP-1 and CLP-7 failed to
cleave standard typical calpain substrates in vitro (data not shown).
Our experiments also revealed that of all the clp genes tested only
clp-1 driven from the unc-54 promoter led to muscle degeneration
and paralysis (Figure S10). The inability of the other atypical
calpains to cause paralysis would indicate that sarcomeric proteins
are either not general substrates for atypical calpains or that they
are inaccessible unless damaged. A third possibility is that an
intracellular inhibitor regulates the activities of atypical calpains.
In mammals, calpastatin directly inhibits CAPN1 and CAPN2
under pathological conditions [74]. The C. elegans genome lacks a
calpastatin gene, but an intracellular serpin protease inhibitor,
SRP-6, has been hypothesized to inhibit TRA-3/CLP-5 and CLP-
10 in the intestine in response to hypo-osmotic shock [37]. A
family of srp genes has been identified, so interactions with other
clp genes might remain to be uncovered.
Calcium activation of atypical calpains
Typical calpain proteases require Ca
2+ for activity, but under
conditions of reduced [Ca
2+]i, they can be stimulated through the
interaction of the C2 domain with membrane phospholipids and
through the autolysis of DI [6,7,15]. So, how does calcium
influence atypical calpain activity? We previously showed that
TRA-3/CLP-5 undergoes calcium-dependent autolysis [34], but it
remains unknown if any of the other atypical calpains can undergo
this process, or if autolysis enhances proteolytic activity. Structural
analyses of a mini-calpain identified two Ca
2+ binding sites within
IIa and IIb of CAPN2 DII, which help to align the catalytic triad
when Ca
2+ is bound [8]. Extrapolating from this model, the
conservation of key residues in DII would predict that atypical
calpains would display a similar Ca
2+ dependency (Figure S2). The
potential influence of phospholipids on the activity of atypical
calpains has yet to be examined, although DIII forms a C2 fold
that could interact with Ca
2+ and phospholipids [75].
It is clear that the physiological rise in [Ca
2+]i achieved through
the use of genetic mutants profoundly affected CLP-1 activity
(Figure 6A). However, it is important to emphasize that it was the
synergistic increase of both CLP-1 and [Ca
2+]i levels that
contributed to paralysis. None of the Ca
2+ channel mutants
examined developed paralysis, indicating that an increase in
[Ca
2+]i by itself is unable to pathologically activate clp-1.
Nonetheless, removal of clp-1 substantially suppressed the muscle
degeneration associated with C. elegans dys-1; hlh-1(cc561ts) DMD,
which is based on a mouse model of myopathy involving the
combined mutation of MyoD and dystrophin (Table 2) [60,76]. In
muscle degenerative conditions, such as DMD, a rise in [Ca
2+]i is
also hypothesized to activate calpain proteolysis [77–79].
We have also shown that the C. elegans hlh-1(cc561ts) allele of a
MyoD homolog, sensitizes C. elegans to the effects of crIs4,a s
measured by the increase in paralysis, and that treatment of these
worms with nemadine-A suppressed paralysis (Figure 7A). As
nemadipine-A is a specific inhibitor of the EGL-19 L-type Ca
2+
channel [72], it was not surprising to find that this drug also
suppressed the paralysis associated with egl-19(gf); crIs4 mutants.
Based on these results, we propose that the hlh-1(cc561ts) mutation
creates a sensitized background for calpain activity by indirectly
elevating [Ca
2+]I, although it remains unclear if EGL-19 activity is
disrupted. Following this logic, we speculate that inappropriate
CLP-1 activity in a sensitized background could generate a
positive feedback loop whereby calpain disrupts Ca
2+ channel
activity, leading to increased [Ca
2+]i, and further activation of
CLP-1. In support of this model, several studies have shown that
typical calpains can cleave Ca
2+ channels and disrupt their
activities [80–82].
Physiological regulation of calpains in muscle
In mammals, inappropriate elevation of either CAPN1 or
CAPN2 is associated with muscle degeneration [54]. Indirect
evidence has also accumulated pointing to the involvement of
these calpains and the skeletal muscle specific CAPN3 isoform in
myofibrillar protein turnover, which promotes the replacement of
damaged sarcomeric components in order to maintain efficient
muscle contraction [7,25,83–88]. What roles do atypical calpains
normally play in muscle? In our study and in reports by others,
only the clp-1 and clp-4 genes appear to be expressed in muscle
(Figure 3) [35,89], and it was further found that a rescuing tra-3/
clp-5::gfp translational fusion was not expressed in muscle [90].
Surprisingly, it has recently been reported that chronic RNAi
knockdown of clp-1, clp-4, tra-3/clp-5, clp-6 or clp-7 was responsible
for causing myofilament disruption [91], suggesting that calpains
are involved in myofilament maintenance. By contrast, we failed to
detect sarcomeric abnormalities in similarly staged adults when
phalloidin was used to examine the body wall muscle of animals
carrying deletion alleles in clp-1, clp-4, clp-6 or clp-7 (Figure S5). We
are unable to account for these differences, although it has been
reported elsewhere that a GFP-tagged myosin heavy chain
reporter [myo-3::gfp] can independently cause an age-dependent
sarcopenia in adults [92]. Nonetheless, our study independently
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complexes and turnover of myofibrillar proteins.
We have obtained evidence that CLP-1 has the potential to
disrupt sarcomeric integrity, indicating that CLP-1 is likely to
target components of muscle adhesion complexes for destruction
(Figure 4 and Figure 6). The localization of CLP-1 to M-lines and
to structures immediately adjacent to Z-disks shows that CLP-1 is
well positioned to participate in myofibrillar turnover or possibly
remodelling of integrin-based muscle attachment assemblies
(Figure 5); however, it is interesting that CLP-1 is excluded from
dense bodies (Z-disks). CLP-1 could also regulate muscle cell-
muscle cell interactions through its localization to adhesion
plaques. In C. elegans, studies based on the use of FRAP show
that C. elegans sarcomeric proteins undergo dynamic exchange
suggestive of protein turnover [93]. Taken together, these
observations suggest that CLP-1 might normally promote
myofibrillar protein turnover and help to maintain the ordered
alignment of adhesion complexes, or to accommodate changes to
the sarcomere due to growth or cell damage. Evidence has also
been obtained from mammalian systems indicating that the typical
CAPN1 and CAPN2 calpains are able to regulate the dynamics of
cell adhesion complexes [18], which are similar in composition to
those found in C. elegans muscle [19].
Our data did not support the expectation that disruptions to the
DAPC, an important complex that maintains muscle structural
integrity in humans, would synergize with CLP-1 overexpression
and lead to increased sarcomeric damage and paralysis in worms
(Figure 6B) [70]. However, it has been reported that the C. elegans
DAPC promotes, but is not essential for muscle integrity
[64,69,94,95], so destabilisation of the complex might not be
sufficient to induce damage and heightened myofibril turnover,
despite the increased availability of CLP-1.
A conserved calpain–cathepsin pathway of muscle
degeneration
We propose that the death of muscle cells observed in paralyzed
crIs4 animals is caused by activation of a pathway promoting
necrosis. In mammalian neurons, a model has been proposed
whereby inappropriate increases in [Ca
2+]i caused by insults such
as ischemia/reperfusion injury contribute to the activation of
calpains and lead to the permeabilization of lysosomes. In turn,
lysosomal rupture allows cathepsin proteases to leak into the cell
and cause widespread degradation and necrotic cell death [55]. In
C. elegans, support for this model was obtained when it was shown
that clp-1, the aspartyl proteases asp-3 and asp-4 and to a lesser
extent asp-1 were required for the necrotic death of neuronal touch
receptors and vulval uv1 cells [35,36]. Similarly, our data also
revealed the importance of asp-3 in promoting clp-1 mediated
paralysis in muscle (Figure 7B). By contrast to studies in neurons,
we found that asp-4 has a reduced role in muscle degeneration and
that asp-1 doesn’t appear to be active in muscle, although we
obtained evidence that asp-2 participates in this process. We,
therefore, propose that a calpain-cathepsin pathway of degener-
ation has been conserved in C. elegans muscle.
Finally, the ability of nemadipine-A to reduce the level of
paralysis in hlh-1; crIs4 worms shows that physiological conditions
that lead to an indirect increase in [Ca
2+]i can have a destructive
and possibly necrotic outcome in muscle cells by activating
atypical calpain activity (Figure 7A) [96]. Therefore, it will be of
further interest to identify physiological conditions that could lead
to elevated calpain expression or [Ca
2+]i as causative factors in
sarcopenia, a loss in muscle contractility observed in ageing cells
[97,98]. We propose that the identification of atypical calpain
inhibitors would represent a fruitful area for pharmacological
investigation. It should be possible to take advantage of the
paralytic phenotype displayed by hlh-1(cc561ts); crIs4 mutants and
to perform a chemical screen to identify compounds that
ameliorate muscle damage. Such a screen could potentially
identify calcium channel blockers or specific inhibitors of atypical
calpains. Given that atypical calpain genes are also present in
mammals, our results emphasize the importance of investigating
the contribution of atypical calpains to degenerative disorders,
especially under conditions associated with inappropriately
elevated [Ca]I, such as muscular dystrophies, neurodegeneration
and cataract.
Materials and Methods
Blast analyses and protein phylogeny
See Protocol S1 for sequence accession numbers and details
about sequence similarity searches and protein alignments.
A custom profile hidden Markov model was created for each of
the five EF-hand motifs of the penta EF hand, using the following
proteins as a training set: HsCAPN1 (AAH75862.1), HsCAPN2
(NP_001739.2), HsCAPN3/p94 (AAI46650.1), HsCAPN8 (NP_
001137434.1), HsCAPN9 (NP_006606.1), HsCAPN11 (EAX
04252.1), DmCALPA (NP_001097378.1), DmCALPB (NP_
524016.4), DmCALPC (AAF48591.2) and HsGRAN (P28676)
[45]. These full-length proteins were aligned using FSA [48], and
each of the EF hand motifs was sliced out of the alignment, based
on the coordinates provided for the EF hand motifs of HsCAPN1,
to generate five multiple sequence alignment files (MSF) [99]. The
hmmbuild program in the HMMER software package was then
used to create a profile HMM for each of the five EF-hand motifs
[45]; pfam HMM files are available as Text S1. The EF-hand
motif model was validated using true positive penta-EF hand
domain containing proteins CAPNS1 (AAH64998.1) and Sorcin
(AAA92155.1); HsCAPN10 and the C. elegans atypical calpains
were shown to be true negatives. An E-value cutoff level of 0.01
was used.
C. elegans methods
Worms were grown and maintained at 20uC as described [100],
except strains containing hlh-1(cc561ts) II, which were grown at
15uC [101]. The following strains were used: wild-type Bristol N2,
HC46: ccIs4215 [myo-3::gfp::nls] I, LS292: dys-1(cx18)I ,clp-8
[F44F1.3]( ok1878)I ,clp-9 [T11A5.6]( ok1866)I ,clpr-1
[W04A4.4]( ok2601) I, LS505: dyb-1(cx36) I, LS721: stn-1(ok292)
I, LS587: dys-1(cx18)I ;hlh-1(cc561ts) II, LS706: dys-1(cx18)I ;egl-
19(ad695gf) IV, NL2099: rrf-3(pk1426) II, PD4605: hlh-1(cc561ts) II,
clp-1(tm690) III, clp-2 (pk323) III, clp-4 (ok2808) III, clp-10
[W05G11.4]( ok2713) III, JR667: unc-119 (e2498::Tc1) III,
VC591: okIs53 snf-6(ok720) III, dpy-20(e1282) IV, DA695: egl-
19(ad695gf) IV, clp-6 (ok1779) IV, clp-7 (ok2750) IV, itr-1(sy290) dpy-
20(e1282) IV, unc-24(e138) IV, NM1968: slo-1(js379) V, EG1285:
lin-15(n765); oxIs12 [unc-47::gfp+lin-15(+)] X, IM19: urIs13 [unc-
119::gfp (IM#175; rol-6(su1006)], NK358: unc-119(ed4) III; qyIs43,
UG756: bgIs312 (pes-6::gfp), wIs51 [scm::gfp (seam cell)+unc-119(+)].
The clp-1(tm690) III allele (kindly provided by Shohei Mitani) was
sequenced using primers GGATGAGCTCTTCTATCGTG and
GTCTGACCATGGTCCATTCC to confirm the presence of a
624 bp deletion, which is predicted to create a frame-shift at
A(460), and produce a truncated protein of 493 amino acids.
egl-19 encodes an L-type voltage gated Ca
2+ channel; an egl-
19(ad695gf) gain-of-function mutation delays the inactivation of the
EGL-19 L-type voltage gated Ca
2+ channel, and hence leads to
increased [Ca
2+]i [102]. The itr-1 gene encodes an inositol 1,4,5-
triphosphate receptor (IP3R) homolog that resides on the
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2+ into the cytoplasm
in response to IP3 signalling [103]; the itr-1(sy290gf) allele is a gain-
of-function mutation that increases [Ca
2+]i. Because the itr-
1(sy290gf) mutant carries a point mutation and does not display
an obvious phenotype, the dpy-20(e1282) mutation, which is closely
linked to the itr-1 gene, was included to facilitate the identification
of itr-1 homozygotes. To account for potential marker effects,
paralysis was also scored in a dpy-20(e1282); crIs4 genetic
background. slo-1(js379) is a loss-of-function allele of a gene that
encodes a Ca
2+ activated potassium BK channel [104]. The SLO-
1 channel is normally activated by a rise in [Ca
2+]i, which leads to
plasma membrane hyperpolarization. In turn, [Ca
2+]i is reduced
by the inactivation of L-type Ca
2+ channels, such as EGL-19
[65,104,105]. unc-24(e138) is a loss-of-function allele of a gene
encoding a protein containing stomatin-like and lipid transfer
domains that indirectly regulates Na
+ channels, and hence, similar
to slo-1, unc-24 affects [Ca
2+]i through plasma membrane
hyperpolarisation [106–109].
Molecular biology and gene cloning
Primer sequences are available in Protocol S2. Protocol S3
provides details about gene cloning and reporter construction.
RNAi was performed as described by cloning PCR amplified
products into the L4440 RNAi feeding vector [110]. RNAi
constructs for asp-1 to asp-6 were obtained from a library [111].
qPCR
Animals were harvested and RNA was extracted as described by
Hope (1999). cDNA was amplified from 1.5 mg of DNAse treated
mRNA using Taqman Reverse Transcription Reagents (Applied
Biosystems), as directed by the manufacturer. qPCR was performed
in triplicate in 20 ml reactions using Fast SYBR Green Master Mix
(Applied Biosystems) and analysed using Fast System SDS software
(Applied Biosystems); PCR products were verified by agarose gel
electrophoresis. Gene expression data were analysed using the
DDCT method and normalized using ama-1 as an endogenous
reference gene relative to N2 wildtype animals [112]. Primers were
designed to span exon-exon boundaries and when applicable,
mRNA was amplified upstream of mutant deletion/insertion sites.
The primers used are listed as follows: ama-1 (PK1084/PK1085);
clp-1 (PK1062/PK1063); clp-2 (PK1113/PK1114); clp-3 (PK1066/
PK1067); clp-4 (clp-4_f2/clp-4_r2); clp-6 (clp-6_f2/clp-6_r2); clp-7
(PK1074/PK1087); clp-8 (clp-8_f2/clp-8_r2); clp-9 (clp-9_f2/clp-
9_r2); clp-10 (clp-10_f2/clp-10_r2); clpr-1 (clpr1_f2/clpr1_r2); asp-1
(PK1095/PK1096); asp-2 (PK1097/PK1098); asp-3 (PK1099/
PK1100); asp-4 (PK1101/PK1102); asp-5 (PK1103/PK1104); asp-
6 (PK1105/PK1106).
Generation of transgenic animals
Worms were transformed by germ line microinjection [113].
Microinjection solutions werecomposed of the plasmid of interest at
10 mg/ml and a co-transformation marker, either 80 mg/ml of
pRF4 rol-6 (su1006)o r5 0mg/ml of TG96 sur-5p::gfp. At least three
independent transgenic strains were generated and examined for
each construct, but only those displayed in this manuscript are
listed, as they are representative of the patterns observed for a given
construct. The following extrachromosomal arrays were generated
with the pRF4 co-transformation marker: crEx65 (clp-1p::nls::mrfp),
crEx70 (clp-2p::nls::mrfp), crEx72 (clp-3p::nls::mrfp), crEx74 (clp-
4::nls::mrfp), crEx78 (tra-3p::nls::mrfp), crEx83 (clp-6p::nls::mrfp), crEx79
(clp-7::nls::mrfp), crEx202 (clp-1p::gfp), crEx110 (hsp-16.64p::clp-1),
crEx86 (hsp-16.64p::clp-2), crEx88 (hsp-16.64p::clp-4), crEx8 (hsp-
16.64p::tra-3), crEx96 (hsp-16.64p::clp-7) and crEx333 (unc-54p::clp-
1::mrfp). The following extrachromosomal arrays were generated
with the TG96 co-transformation marker: crEx325 (unc-54p::clp-1),
crEx141 (unc-54p::clp-2), crEx147 (unc-54p::clp-4), crEx263 (unc-
54p::tra-3), crEx258 (unc-54p::clp-7), crEx241 (unc-47p::clp-1), crEx190
(unc-119p::clp-1), crEx319 (unc-54p::clp-1(C371A)), crEx335 (unc-
54p::clp-1::mrfp) and crEx336 (unc-54p::clp-1(C371A)::mrfp).
The unc-54p::clp-1(crEx325) extrachromosomal array, crEx325
was chromosomally integrated by gamma irradiation using a
137Cs
source (RX30/50, Gravatom Industries). The integrated strain,
crIs4 (unc-54p::clp-1) was outcrossed five times with N2 prior to
study.
Phenotypic analyses
Tissue-specific GFP reporters used to identify tissues expressing
calpain reporters include: unc-119::gfp, a pan-neuronal marker
[114]; unc-47::gfp, which is specifically expressed in GABAergic
neurons of the ventral nerve cord [115]; myo-3::gfp::nls, which is
expressed in all muscle cells except those of the pharynx [116];
scm::gfp, a seam cell marker [117]; and pes-6::gfp, a excretory cell
GFP reporter.
Brood size and embryonic lethality was scored by placing
individual L4 staged hermaphrodites on NGM plates and
transferring them daily to a fresh plate until egg laying had
ceased. The number of dead eggs (embryonic lethality) and live
animals (brood size) were scored two days after transfer of the
mother.
The percentage of animals displaying paralysis was scored on
day 2 of adulthood after first obtaining synchronized populations
of animals of the specified genotype by bleaching gravid adults
with alkaline hypochlorite [118]. Phenotypic scoring was per-
formed by gently prodding animals with a platinum pick and
registering their response: Unc animals retained the ability to
move, but with impaired mobility; paralyzed animals failed to
migrate.
Phalloidin staining
Animals were stained with Alexa Fluor 594 phalloidin
(Invitrogen). Briefly, day 2 adults displaying wildtype, Unc or
paralyzed phenotypes were lyophilized in an Automatic Environ-
mental Speedvac (Savant) prior to fixation in ice-cold acetone.
Animals were resuspended in 20 ml S-Mix (0.2 M Na phosphate
(pH 7.5), 1 mM MgCl2, 0.004% (w/v) SDS) containing 2 U Alexa
Fluor 594 phalloidin, incubated for 1 hour in the dark and washed
twice with PBS-Tween 20 (0.5%) (Sigma) before viewing.
Western blotting
Eighty day 2 adult animals were placed in 20 ml of SDS protein
sample buffer, electrophoresed on 10% or 4–12% gradient SDS-
polyacrylamide gels and transferred to nitrocellulose membranes.
Blots were incubated with primary antibodies at the following
concentrations: anti-mRFP/GFP primary antibody (Invitrogen),
1:1000; anti-myc 9E10, 1:1000; anti-a tubulin (Abcam), 1:4000;
anti-actin (Sigma), 1:1000. Protein was visualized using anti-mouse
or anti-rabbit horseradish peroxidase (HRP) linked antibodies
(Amersham) at 1:5000 dilution and Western Lightning
TM
chemiluminescent substrate (Perkin Elmer). Nitrocellulose mem-
branes were stripped using Restore Plus stripping buffer (Thermo
Scientific). Protein levels were quantified using ChemiDoc-It
imaging system (UVP).
Nemadipine-A treatment
Worms were grown in wells of 24-well plates containing 1 ml of
MYOB agar [119], including 5 mM nemadipine-A (kindly
provided by Peter Roy) or 0.01% DMSO (control), as described
Calpain Evolution and Muscle Degeneration
PLoS Genetics | www.plosgenetics.org 12 March 2012 | Volume 8 | Issue 3 | e1002602[72]. Plates were incubated at 20uC, except those carrying hlh-
1(cc561ts) mutants, which were raised at 15uC. Phenotypic scoring
is described above.
Microscopy
Animals were immobilized using 10 mM sodium azide.
Differential interference contrast (DIC) and fluorescent images
were captured with a Zeiss Axioskop 2 fitted with an ORCA-ER
(Hamamatsu) digital camera driven by Openlab 4 software
(Improvision), or a Zeiss LSM 710 confocal driven by Zeiss Zen
software.
Statistical analysis
Statistical analysis was performed using Student’s T-test.
Supporting Information
Figure S1 The modular arrangement of Ca
2+-activated calpain
proteases. Atypical and typical calpains share a conserved
catalytic DII, which is further separated into Ca
2+ binding sites,
IIa and IIb. Residues of the catalytic triad are highlighted with
arrows; missing catalytic residues are marked with an X. Many
calpains have a short non-conserved DI sequence, which are
subject to autolysis, and a DIII that carries a C2 Ca
2+-binding
domain. DIV is exclusive to typical calpains and is distinguished
by the presence of a penta EF-hand domain; the fifth EF-hand
motif mediates heterodimerization with a small regulatory
subunit CAPNS1 (not shown). A number of additional domains
and motifs are also associated with calpain proteins: G and G E,
regions rich in glycine or glycine and glutamate, respectively;
SEEL, a potential C-terminal ER target sequence; PBH, PalB
homology domain with some domain III homology; T, C2
domain originally identified in TRA-3 [33]; Zn
2+, zinc finger
motif-containing; SolH, small optic lobes (SOL) homology
domain; and MIT 1, microtubule interacting and transport
domain.
(TIF)
Figure S2 Sequence alignments of calpain proteins. Protein
sequence alignment of fourteen C. elegans calpains (CLP-1, CLP-2,
CLP-3, CLP-4, TRA-3/CLP-5, CLP-6, CLP-7, CLP-8, CLP-9,
CLP-10, CLPR-1, CLPR-2, CLPR-3, CLPR-4) and human
calpains (CAPN1 and CAPN2). Domains are highlighted with
coloured lines as follows: DI (green), DII (red) and DIII (purple).
The catalytic residues C, H and N are highlighted with red boxes.
Conserved residues involved in coordinating Ca
2+ within DII are
highlighted yellow, and residues R and E which coordinate the
Ca
2+ induced conformational change between domain IIa and IIb
in human CAPN2 are highlighted yellow and indicated with
arrows [8]. Conserved residues from the RanBP2 zinc finger type
signature for CLP-9 are highlighted in light blue. Proteins were
aligned using ClustalW version 1.83 and shaded using GeneDoc
version 2.6.0.2. Black boxes highlight greater than 95% similarity,
dark grey boxes greater than 80% similarity, and light grey boxes
greater than 60% similarity.
(DOC)
Figure S3 Phylogenetic relationships between calpain proteins.
Cladogram of calpain and calpain-like proteins from worm, fly
and human, which is rooted using the prokaryote calpain-related
protein, TPR-1, from Porphyromonas gingivalis (Pg). Prefixes used to
identify species include: C. elegans (Cel), C. briggsae (Cbr), D.
melanogaster (Dm) and H. sapiens (Hs). GenBank accession numbers
are provided in the Methods section.
(TIF)
Figure S4 Identification of proteolytically inactive calpain-like
proteins. (A) Inactive calpain proteins (344) that are missing key
residues of the catalytic triad were identified across all eukaryotic
kingdoms. (B) Inactive calpain proteins (100) were found
distributed across animal phyla, ranging from ancient Placozoa
and Cnidaria to Chordata.
(TIF)
Figure S5 Calpain deletion mutants do not display defects in
body wall muscle. Representative images of phalloidin stained
body wall muscle from (A) clp-1 (tm690), (B) clp-4 (ok2808), (C) clp-6
(ok1779), and (D) clp-7 (ok2750) deletion mutants at day 3 of
adulthood. Following phalloidin staining, the 20 most central
muscle cells from each of the two most visible body wall muscle
quadrants were scored (40 cells per animal), as described in
Gieseler et al. (2000). Abnormal body wall muscle cells were not
seen in any of the four clp mutants from 3 independent
experiments involving at least 30 animals per experiment. Scale
bar is 20 mm.
(TIF)
Figure S6 Expression patterns of five C. elegans atypical calpain
transcriptional reporters. (A) Basic construction of nls::mrfp
expression reporters driven from calpain promoters. (B–F) Nuclear
localized expression patterns of calpain reporters in adult
hermaphrodites. (B) clp-1p::nls::mrfp (crEx65) (C) clp-2p::nls::mrfp
(crEx70) (D) clp-4p::nls::mrfp (crEx74) (E) tra-3p::nls::mrfp (crEx78) (F)
clp-7p::nls::mrfp (crEx79). Each micrograph is typical of the pattern
observed with at least two other independent transgenic strains
generated with the same reporter construct. Nomarski DIC
micrograph, left; mRFP fluorescence micrograph, right. A
montage of overlapping images captured in the same focal plane
was created to show the entire worm. Scale bar, 50 mM.
(TIF)
Figure S7 Larval stage expression patterns of five C. elegans
atypical calpain transcriptional reporters. (A–E) Nuclear localized
expression patterns of calpain reporters at different larval stages.
(A) L2 larvae expressing clp-1p::nls::mrfp (crEx65), (B) L3 larvae
expressing clp-2p::nls::mrfp (crEx70), (C) L4 larvae expressing clp-
4p::nls::mrfp (crEx74), (D) L2 larvae expressing tra-3p::nls::mrfp
(crEx78), (E) L1 larvae expressing clp-7p::nls::mrfp (crEx79). No-
marski DIC micrograph, left; mRFP fluorescent micrograph,
right. Scale bar, 10 mM.
(TIF)
Figure S8 Co-localization of calpain nls::mrfp transcriptional
reporters and the GABA-ergic unc-47::gfp reporter. (A) clp-
1p::nls::mrfp (crEx65) (B) clp-4p::nls::mrfp (crEx74), and (C) clp-
7p::nls::mrfp (crEx79) co-localize with the unc-47::gfp reporter. unc-
47::gfp reporter, left (green); calpain promoter driven nls::mrfp
expression, middle (red); and co-localization, right (yellow). The
tra-3/clp-5::mrfp reporter fails to co-localize with unc-47::gfp (data
not shown). Each micrograph is typical of the pattern observed
with at least two other independent transgenic strains generated
with the same reporter construct. Scale bar, 10 mM.
(TIF)
Figure S9 Atypical calpain expression is associated with the
intestine, vulva and hypodermis. Intestinal expression, indicated
with arrows, is detected in (A) clp-2p::nls::mrfp (crEx70), (B) tra-
3p::nls::mrfp (crEx78) and (C) clp-7p::nls::mrfp (crEx79). tra-3p::nls::mrfp
(crEx78) is expressed in (D) the vulva and (E) the hypodermis. clp-
7p::nls::mrfp (crEx79) is expressed in (F) the vulva and (G) the
hypodermis. Vulval and hypodermal expression are indicated with
a (v) and arrowheads, respectively. Nomarski DIC micrographs
were overlaid with false colored mRFP fluorescence micrographs,
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is typical of the pattern observed with at least two other
independent transgenic strains generated with the same reporter
construct. Scale bar, 10 mm.
(TIF)
Figure S10 Test to discriminate between phenotypically Unc
and paralyzed adult animals expressing unc-54p::clp-1. Animals
were mechanically prodded (arrowhead) at t=0 and examined for
their ability to move away from a stimulus over a 10 s interval.
Unc animals (top panel) are able to change body position, but have
impaired mobility. Paralyzed animals (middle panel) show
marginal movement of head and/or tail and an absence of
mobility. The behavior of a wildtype adult (bottom panel) is shown
by comparison. The time elapsed after the application of
mechanical stimulus is indicated. Scale bars, 500 mm.
(TIF)
Figure S11 Detection and comparison of transgenic CLP-
1::mRFP protein levels. (A) CLP-1::myc levels in N2 wildtype,
unc-54p::clp-1::myc (crEx325) and hsp16-41p::clp-1::myc (crEx329)
animals without (2HS) and four hours after heat shock (+HS).
a-tubulin (TBA) provides a protein loading reference and CLP-
1::myc expression levels are presented as a percentage of unc-
54p::clp-1::myc protein levels and normalized to TBA. (B) CLP-
1::myc expression levels in N2 wildtype and in hsp16-41p::clp-1::myc
(crEx329) animals taken at intervals following heat shock. TBA
provides a protein loading reference. CLP-1::myc expression levels
are presented as a percentage of hsp16-41p::clp-1::myc protein levels
8 hours post heat shock and normalized to TBA. (C) CLP-
1::mRFP protein expression levels in wildtype unc-54p::clp-1::mrfp
(crEx335) and catalytically inactive unc-54p::clp-1(C371A)::mrfp
(crEx336) animals. Actin was used as a protein loading reference.
CLP-1::mRFP expression levels are presented as a percentage of
unc-54p::clp-1::mRFP protein levels and normalized to actin.
Values represent the average from two independent experiments.
(TIF)
Figure S12 Translational expression pattern of clp-1::gfp. (A) clp-
1::gfp (crEx202) is expressed throughout the animal. Scale bar,
50 mM. (B–F) clp-1::gfp (crEx202) is expressed in many somatic
tissues, including: (B) the head – pharyngeal muscles and the nerve
ring, (C) body wall muscle, (D) the ventral nerve cord and muscle
arms (white arrows), (E) vulva, (F) intestine. Each micrograph is
typical of the pattern observed with at least two other independent
transgenic clp-1::gfp strains. Scale bar, 10 mM.
(TIF)
Protocol S1 Protein blast and phylogenetic analyses.
(DOC)
Protocol S2 Oligonucleotide sequences.
(DOC)
Protocol S3 Molecular biology and gene cloning methods.
(DOC)
Table S1 Eukaryotic catalytically inactive calpains.
(DOC)
Table S2 Effects of calpain mutants and feeding RNAi on brood
size and embryonic lethality.
(DOC)
Table S3 Effects of ectopic clp-1 expression on brood size and
embryonic lethality.
(DOC)
Table S4 qPCR analysis of asp-1 to asp-6 (RNAi).
(DOC)
Text S1 Profile hidden Markov models detecting EF hand
motifs.
(TXT)
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